SOPHiA GENETICS
SOPH
SOPH
36 hedge funds and large institutions have $81.4M invested in SOPHiA GENETICS in 2023 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 11 increasing their positions, 6 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0.54% more ownership
Funds ownership: 26.05% → 26.59% (+0.54%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
36
Holding in Top 10
1
Calls
$18K
Puts
–
Top Buyers
| 1 | +$942K | |
| 2 | +$584K | |
| 3 | +$281K | |
| 4 |
LCM
Legato Capital Management
San Francisco,
California
|
+$235K |
| 5 |
Morgan Stanley
New York
|
+$207K |
Top Sellers
| 1 | -$202K | |
| 2 | -$189K | |
| 3 | -$188K | |
| 4 |
JPMorgan Chase & Co
New York
|
-$140K |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
-$123K |